Evolent Health (EVH) Preferred Stock Liabilities (2014 - 2025)

Evolent Health's Preferred Stock Liabilities history runs 4 years deep, the most recent figure standing at $228.8 million for Q2 2025.

• On a quarterly basis, Preferred Stock Liabilities rose 24.21% year-over-year to $228.8 million in Q2 2025; TTM through Jun 2025 was $228.8 million, a 24.21% increase from a year earlier, with the FY2024 full-year figure at $190.2 million, up 6.58% from the prior year.
• Preferred Stock Liabilities climbed to $228.8 million in Q2 2025 per EVH's latest filing, from $193.2 million in the prior quarter.
• Across five years, Preferred Stock Liabilities topped out at $228.8 million in Q2 2025 and bottomed at $170.6 million in Q1 2023.
• The 3-year median for Preferred Stock Liabilities is $182.8 million (2024), against an average of $186.2 million.
• Across the five-year window, Preferred Stock Liabilities gained 6.25% in 2024 and grew 24.21% in 2025, its largest moves.
• Year by year, Preferred Stock Liabilities stood at $178.4 million in 2023, then rose by 6.58% to $190.2 million in 2024, then advanced by 20.31% to $228.8 million in 2025.
• Per Business Quant, the three latest EVH Preferred Stock Liabilities figures stand at $228.8 million (Q2 2025), $193.2 million (Q1 2025), and $190.2 million (Q4 2024).